MapLight Therapeutics CEO Sells Shares Worth More Than $595,000

Christopher A. Kroeger sold vested restricted stock units in a mandated sell-to-cover transaction. The shares were sold at a weighted average price of $8.08, with individual sale prices ranging from $7.755 to $8.3732.